参考文献/References:
[1] 崔力方, 曲丛玲, 赵洪禹, 等. 喉鳞状细胞癌组织HPV16 和p16 表达的临床意义[J]. 中华肿瘤防治杂志, 2021, 28(9): 661-667. CUI Lifang, QU Congling, ZHAO Hongyu, et al. Clinical significance of HPV16 and p16 expression in laryngeal squamous cell carcinoma[J]. Chinese Journal of Cancer Prevention and Treatment, 2021, 28(9): 661-667.
[2] SEEBAUER C T, HACKENBERG B, GROSSE J, et al. Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma-a review[J].Strahlentherapie und Onkologie, 2021, 197(3): 167-176.
[3] DUBEY P, GUPTA R, MISHRA A, et al. Evaluation of correlation between CD44, radiotherapy response,and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC)[J].Cancer Medicine, 2022, 11(9): 1937-1947.
[4] 马炜祥, 张婷婷, 崔凤针, 等. 内质网应激关键分子ATF6α 在癌症中作用的研究进展[J]. 华中科技大学学报( 医学版), 2022, 51(2):241-246, 253. MA Weixiang, ZHANG Tingting, CUI Fengzhen,et al. Role of endoplasmic reticulum stress key molecule ATF6α in cancer development[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong(Medical Edition), 2022, 51(2): 241-246,253.
[5] BLAAUBOER A, SIDERAS K, VAN EIJCK C H J, et al. Type I interferons in pancreatic cancer and development of new therapeutic approaches[J]. Critical Reviews in Oncology Hematology, 2021, 159: 103204.
[6] GRILO A L, MANTALARIS A. Apoptosis: a mammalian cell bioprocessing perspective[J].Biotechnology Advances, 2019, 37(3): 459-475.
[7] 彭丽娜, 武川军, 冯志星, 等. IDO1 和IL-10 在喉鳞状细胞癌组织中的表达及其与临床病理特征和预后的关系研究[J]. 中国现代医学杂志, 2022, 32(1):69-74. PENG Lina, WU Chuanjun, FENG Zhixing, et al. Expression of IDO1 and IL-10 in laryngeal squamous cell carcinoma and their relationship with clinicopathological features and prognosis[J]. China Journal of Modern Medicine, 2022, 32(1): 69-74.
[8] VAN DEN BOSCH S, CZERWINSKI M, GOVERS T,et al. Diagnostic test accuracy of sentinel lymph node biopsy in squamous cell carcinoma of the oropharynx,larynx, and hypopharynx: A systematic review and meta-analysis[J]. Head & Neck, 2022, 44(11): 2621-2632.
[9] 冯成敏, 朱鑫, 程瑶, 等. 喉鳞状细胞癌组织中MUC13 的表达及临床意义[J]. 川北医学院学报,2023, 38(2):160-164. FENG Chengmin, ZHU Xin, CHENG Yao, et al. Expression and clinical significance of MUC13 in laryngeal squamous cell carcinoma[J]. Journal of North Sichuan Medical College, 2023, 38(2): 160-164.
[10] MADDEN E, LOGUE S E, HEALY S J, et al. The role of the unfolded protein response in cancer progression:From oncogenesis to chemoresistance[J].Biology of the Cell, 2019, 111(1): 1-17.
[11] COLEMAN O I, HALLER D. ER stress and the UPR in shaping intestinal tissue homeostasis and immunity[J].Frontiers in Immunology, 2019, 10: 2825.
[12] PENG Fusen, ZHANG Hailin, DU Youhong, et al. Cetuximab enhances cisplatin-induced endoplasmic reticulum stress-associated apoptosis in laryngeal squamous cell carcinoma cells by inhibiting expression of TXNDC5[J]. Molecular Medicine Reports, 2018,17(3): 4767-4776.
[13] 李倩, 范妤, 史晓燕, 等. 内质网应激诱导的自噬在肝脏疾病中的研究进展[J]. 生命科学, 2021, 33(7):876-887. LI Qian, FAN Yu, SHI Xiaoyan, et al. Research progress of endoplasmic reticulum stress-induced autophagy in liver diseases[J]. Chinese Bulletin of Life Sciences, 2021, 33(7): 876-887.
[14] JEON Y J, KIM T, PARK D, et al. MiRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC[J]. Nature Communications, 2018, 9(1): 5110.
[15] LI Ruohan, ZHOU Huaixiang, LI Mingzhe, et al. Gremlin-1 promotes colorectal cancer cell metastasis by activating ATF6 and inhibiting ATF4 pathways[J].Cells, 2022, 11(14): 2136.
[16] KANG J I, KIM D H, SUNG K W, et al. p62-induced cancer-associated fibroblast activation via the Nrf2-ATF6 pathway promotes lung tumorigenesis[J].Cancers, 2021, 13(4): 864.
[17] 柳青, 田娜, 王慧杰. 食管癌患者血清中血管内皮生长因子和胰岛素样生长因子-1 表达及其与临床病理特征的关系[J]. 实用癌症杂志, 2022, 37(1):54-56,67. LIU Qing, TIAN Na, WANG Huijie. The expresssion of VEGF and IGF-1 in esophageal cancer and its clinical significance[J]. The Practical Journal of Cancer, 2022,37(1): 54-56, 67.
[18] 姜秋利, 鲁华东, 郑景妹, 等. 结直肠癌组织中RREB1 和ANKRD1 的表达与临床病理特征和预后的相关性研究[J]. 现代检验医学杂志, 2023, 38(1):16-21. JIANG Qiuli, LU Huadong, ZHENG Jingmei, et al. Correlation between the expression of RREB1 and ANKRD1 and clinicopathological features and prognosis in colorectal cancer[J]. Journal of Modern Laboratory Medicine, 2023, 38(1): 16-21.
[19] SHI Weiye, YAO Xu, FU Yu, et al. Interferon-α and its effects on cancer cell apoptosis[J]. Oncology Letters,2022, 24(1): 235.
[20] 刘美君, 丁治国, 陈晓珩, 等. 参芪注射液协同IFN-α 抑制肝癌细胞体外增殖、迁移能力和侵袭性的研究[J]. 中国现代普通外科进展, 2022, 25(12):925-927, 932. LIU Meijun, DING Zhiguo, CHEN Xiaohang, et al. Shenqi Fuzheng injection combined with interferon alpha on the proliferation and invasiveness of hepatocellular carcinoma cells in vitro[J]. Chinese Journal of Current Advances in General Surgery, 2022,25(12): 925-927, 932.
[21] TIRONE N R, CAMPOS C G, FERREIRA K J A, et al. Pathways of IFN-alpha activation in patients with Cervical Intraepithelial Neoplasia (CIN)[J]. Revista Brasileira De Ginecologia e Obstetricia, 2021, 43(9):682-689.
[22] 谢淼, 沙文, 崔庆明, 等. 等离子电切术联合丝裂霉素C 及干扰素-α 膀胱灌注化疗治疗浅表性膀胱癌的疗效及预后分析[J]. 癌症进展, 2020, 18(2):195-197. XIE Miao, SHA Wen, CUI Qingming, et al. Efficacy and prognosis of plasmakinetic resection combined with intravesical instillation of mitomycin C and interferon-a in the treatment of superficial bladder cancer[J]. Oncology Progress, 2020, 18(2): 195-197.